project id: TCGA-BLCA; case submitter id: TCGA-DK-AA6T; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.46; rna integrity number: 8.4; age at index: 63; days to birth: -23198; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1950; age at diagnosis: 23198; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 572.0; icd 10 code: C67.0; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Trigone of bladder; synchronous malignancy: No; tissue or organ of origin: Trigone of bladder; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 186; initial weight: 80.0; sample id: a886d3cb-5733-4a50-8ddb-1fb7fb8c4f71; sample submitter id: TCGA-DK-AA6T-01A; portion id: 2eab3492-995c-4f54-8a09-0cb2286dc782; portion submitter id: TCGA-DK-AA6T-01A-11; slide id: 789b1afb-6fa0-47a9-a8ef-797b0d29fdf0; slide submitter id: TCGA-DK-AA6T-01A-01-TS1; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 25.0; percent stromal cells: 0.0; percent tumor cells: 75.0; percent tumor nuclei: 65.0; section location: TOP;